- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Epilepsy Research and Treatment
Volume 2012 (2012), Article ID 382095, 8 pages
doi:10.1155/2012/382095
Selective Amygdalohippocampectomy
1Department of Neurology, Oregon Health & Science University, Portland, OR 9739, USA
2Department of Neurological Surgery, Oregon Health & Science University, Portland, OR 97239, USA
Received 8 November 2010; Revised 22 February 2011; Accepted 25 March 2011
Academic Editor: Seyed M. Mirsattari
Copyright © 2012 David Spencer and Kim Burchiel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Epilepsy surgery can be an effective epilepsy treatment for patients whose seizures do not respond to best medical therapy. For patients with temporal lobe epilepsy, selective amygdalohippocampectomy (SAH) has emerged as a viable alternative to standard anterior temporal lobectomy. This paper reviews the indications for SAH, the technical advances that have led to greater adoption of the procedure, the expectations for seizure control, and the risks of morbidity.